Quest diagnostics partners with cdc to extend $0 out-of-pocket covid-19 diagnostic testing to underserved communities

Qualified uninsured individuals now have access to the company's covid-19 molecular diagnostic testing at approximately 1,200 quest diagnostics patient service centers secaucus, n.j. , july 7, 2022 /prnewswire/ -- quest diagnostics (nyse: dgx), the world's leading provider of diagnostic information services, today announced it is now a participating partner in the centers for disease control and prevention's (cdc) increasing community access to testing (icatt) for covid-19 program, which is designed to support free covid-19 laboratory testing for patients in u.s. communities that have been disproportionately affected by the pandemic.
DGX Ratings Summary
DGX Quant Ranking